Real-time enrollment status for this metastatic castrate-resistant prostate cancer (mcrpc) clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:27 PM UTC
| NCT Number | NCT06046040 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castrate-Resistant Prostate Cancer (mCRPC) |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Pennsylvania |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of July 16, 2026: Clinical trial NCT06046040 is currently recruiting participants. This phase1 study for metastatic castrate-resistant prostate cancer (mcrpc) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Pennsylvania. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06046040 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06046040 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.